Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26709231 | 0.79 | CYP2C9 (0.38) | CYP2C9EPHX2EPHX1HSD11B1 | |
| SCHEMBL4067305 | 0.77 | CYP2C9 (0.38) | CYP2C9EPHX2EPHX1 | |
| SCHEMBL12193712 | 0.75 | CYP2C9 (0.35) | CYP2C9EPHX2 | |
| SCHEMBL26370610 | 0.72 | CYP2C9 (0.35) | CYP2C9EPHX2 | |
| SCHEMBL25630117 | 0.72 | CYP2C9 (0.35) | CYP2C9EPHX2 | |
| SCHEMBL26364080 | 0.72 | CYP2C9 (0.35) | CYP2C9EPHX2 | |
| SCHEMBL2982997 | 0.72 | CYP2C9 (0.41) | CYP2C9EPHX2HSD11B1 | |
| SCHEMBL3282039 | 0.72 | CYP2C9 (0.35) | CYP2C9EPHX2 | |
| SCHEMBL22073526 | 0.72 | CYP2C9 (0.35) | CYP2C9EPHX2 | |
| SCHEMBL6346244 | 0.72 | CYP2C9 (0.36) | CYP2C9EPHX2EPHX1HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6872846-B2 | Process for preparation of tertiary alcohol esters | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2005-03-29 | — | — | US | disclosed |
| US-20040015006-A1 | Efficient one pot process | DAICEL CHEMICAL INDUSTRIAL, LTD. (JP) | 2004-01-22 | — | — | US | disclosed |
| EP-1344762-A1 | PROCESS FOR PREPARATION OF TERTIARY ALCOHOL ESTERS | Daicel Chemical Industries, Ltd. (JP) | 2003-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040015006-A1 | Efficient one pot process | ADH1A, ADH1C, ADH5 | CYP2C9 487/4885EPHX2 681/4885EPHX1 1397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.